Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Total Non-Current Liabilities: 2011-2024

Historic Total Non-Current Liabilities for Mimedx Group (MDXG) over the last 14 years, with Dec 2024 value amounting to $63.4 million.

  • Mimedx Group's Total Non-Current Liabilities rose 24.29% to $74.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $74.5 million, marking a year-over-year increase of 24.29%. This contributed to the annual value of $63.4 million for FY2024, which is 32.60% down from last year.
  • Latest data reveals that Mimedx Group reported Total Non-Current Liabilities of $63.4 million as of FY2024, which was down 32.60% from $94.1 million recorded in FY2023.
  • Mimedx Group's Total Non-Current Liabilities' 5-year high stood at $106.9 million during FY2020, with a 5-year trough of $63.4 million in FY2024.
  • Its 3-year average for Total Non-Current Liabilities is $83.2 million, with a median of $92.2 million in 2022.
  • As far as peak fluctuations go, Mimedx Group's Total Non-Current Liabilities rose by 2.12% in 2023, and later plummeted by 32.60% in 2024.
  • Mimedx Group's Total Non-Current Liabilities (Yearly) stood at $106.9 million in 2020, then dropped by 15.32% to $90.5 million in 2021, then rose by 1.84% to $92.2 million in 2022, then rose by 2.12% to $94.1 million in 2023, then tumbled by 32.60% to $63.4 million in 2024.